Slideshow
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
This slideshow reviews drug information for INLYTA® (axitinib), indicated for advanced renal cell carcinoma.
Table of Contents
Slide 3: Indication, Dosage, and Administration
Slide 6: Use in Specific Populations
Slide 9: Clinical Pharmacology
Slide 13: Warnings and Precautions
Slide 17: Clinical Safety and Efficacy
Slide 23: Drug Storage and Supply